InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Neylan John F., Autre. Director active across 2 companies, notably Angion Biomedica Corp.. Cumulatively, 17 disclosures have been recorded. Split: 0 buy · 16 sells. Total volume traded: €45k. History available since 18 May 2021. The latest transaction was filed on 20 December 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
358 shares@ US$2.62011.8% of flowCommon StockSEC:0001601485-21-000091
358 shares@ US$2.62011.8% of flowCommon StockSEC:0001601485-21-000091:0
374 shares@ US$4.133.0% of flowCommon StockSEC:0001601485-21-000077
374 shares@ US$4.133.0% of flowCommon StockSEC:0001601485-21-000077:0
373 shares@ US$8.626.1% of flowCommon StockSEC:0001601485-21-000062:0
373 shares@ US$8.626.1% of flowCommon StockSEC:0001601485-21-000062
376 shares@ US$10.077.1% of flowCommon StockSEC:0001601485-21-000058:0
376 shares@ US$10.077.1% of flowCommon StockSEC:0001601485-21-000058
381 shares@ US$9.036.5% of flowCommon StockSEC:0001601485-21-000052
381 shares@ US$9.036.5% of flowCommon StockSEC:0001601485-21-000052:0
365 shares@ US$10.987.5% of flowCommon StockSEC:0001601485-21-000038
365 shares@ US$10.987.5% of flowCommon StockSEC:0001601485-21-000038:0
366 shares@ US$13.208.9% of flowCommon StockSEC:0001601485-21-000029:0
366 shares@ US$13.208.9% of flowCommon StockSEC:0001601485-21-000029
363 shares@ US$13.919.1% of flowCommon StockSEC:0001601485-21-000025
363 shares@ US$13.919.1% of flowCommon StockSEC:0001601485-21-000025:0
53,750 sharesCommon StockSEC:0000899243-16-012464:0
17 of 17 declarations
About Neylan John F.
Neylan John F. is an executive at Angion Biomedica Corp.
